Was The Smart Money Right About Crowding Into Iovance Biotherapeutics, Inc. (IOVA)?
In this article we are going to use hedge fund sentiment as a tool and determine whether Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a good investment right now.
Iovance Biotherapeutics Inc. (IOVA)
Market is closed
News
- First
- << Previous
- 51 - 60
- Next >>
Hedge Funds Can't Buy Enough Of Iovance Biotherapeutics, Inc. (IOVA)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Were Hedge Funds Right About Iovance Biotherapeutics, Inc. (IOVA)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Aren't Done Buying Iovance Biotherapeutics, Inc. (IOVA)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Hedge Funds Have Never Been This Bullish On Iovance Biotherapeutics, Inc. (IOVA)
Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Imminent...
How Did Iovance Biotherapeutics, Inc. (IOVA) Perform In Comparison to Hedge Fund Favorites in 2019?
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Hedge Funds Have Never Been This Bullish On Iovance Biotherapeutics, Inc. (IOVA)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Hedge Funds Are Dumping Iovance Biotherapeutics, Inc. (IOVA)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Did Hedge Funds Drop The Ball On Iovance Biotherapeutics, Inc. (IOVA) ?
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment that leads to companies...
Here's What Hedge Funds Think About Iovance Biotherapeutics, Inc. (IOVA)
During the fourth quarter the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 7 percentage points as investors worried over the possible ramifications of rising interest rates.
- First
- << Previous
- 51 - 60
- Next >>
Billionaire Hedge Funds
